N-acetylcysteine compared to metformin, improves the expression profile of growth differentiation factor-9 and receptor tyrosine kinase c-kit in the oocytes of patients with polycystic ovarian syndrome

International Journal of Fertility and Sterility

Volumn 11, Issue 4, 2018, Pages 270-278

  Cheraghi, Ebrahim ^a   Soleimani Mehranjani, Malek ^b   Shariatzadeh, Seyed Mohammad Ali ^b   Nasr Esfahani, Mohammad Hossein ^c   Alani, Behrang ^d  

^a UNIVERSITY OF QOM   (Iran)

^b ARAK UNIVERSITY   (Iran)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^d KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene expression; Metformin; N acetylcysteine; Oocyte; Polycystic ovarian syndrome

Indexed keywords

ACETYLCYSTEINE; ANDROSTENEDIONE; BONE MORPHOGENETIC PROTEIN 15; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GROWTH DIFFERENTIATION FACTOR 9; LUTEINIZING HORMONE; METFORMIN; PROGESTERONE; PROTEIN TYROSINE KINASE; RECOMBINANT FOLLITROPIN; STEM CELL FACTOR RECEPTOR; TESTOSTERONE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR ASPIRATION; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NAUSEA; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; UROGENITAL SYSTEM PARAMETERS; WESTERN BLOTTING;

EID: 85031793343     PISSN: 2008076X     EISSN: 20080778     Source Type: Journal    
DOI: 10.22074/ijfs.2018.5142     Document Type: Article

References (36)

1. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8: 41.
2. Balen AH, Rutherford AJ. Managing anovulatory infertility and polycystic ovary syndrome. BMJ. 2007; 335(7621): 663-666.
3. Qiao J, Feng HL. Extra-and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011; 17(1): 17-33.
4. Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update. 2008; 14(2): 159-177.
5. Knight PG, Glister C. TGF-β superfamily members and ovarian follicle development. Reproduction. 2006; 132(2): 191-206.
6. Celestino JJH, Matos MHT, Saraiva MVA, Figueiredo JR. Regulation of ovarian folliculogenesis by Kit Ligand and the c-Kit system in mammals. Anim Reprod. 2009; 6(3): 431-439.
7. Tuck AR, Robker RL, Norman RJ, Tilley WD, Hickey TE. Expression and localisation of c-kit and KITL in the adult human ovary. J Ovarian Res. 2015; 8: 31.
8. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87(3): 1337-1344.
9. Zhao SY, Qiao J, Chen YJ, Liu P, Li J, Yan J. Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome. Fertil Steril. 2010; 94(1): 261-267.
10. Persani L, Rossetti R, Di Pasquale E, Cacciatore C, Fabre S. The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders. Hum Reprod Update. 2014; 20(6): 869-883.
11. Palomba S, Falbo A, La Sala GB. Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2014; 12: 3.
12. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003; 327(7421): 951-953.
13. Kjøtrød SB, von Düring V, Carlsen SM. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod. 2004; 19(6): 1315-1322.
14. Tang T, Glanville J, Orsi N, Barth JH, Balen AH. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21(6): 1416-1425.
15. Liu J, Liu M, Ye X, Liu K, Huang J, Wang L, et al. Delay in oocyte aging in mice by the antioxidant N-acetyl-l-cysteine (NAC). Hum Reprod. 2012; 27(5): 1411-1420.
16. th Annual Meeting of ESHRE; 2009 Jun-Jul 28-1; Amsterda; the Netherlands; 2009.
17. Mahmoodi M, Soleimani Mehranjani M, Shariatzadeh SM, Eimani H, Shahverdi A. N-acetylcysteine improves function and follicular survival in mice ovarian grafts through inhibition of oxidative stress. Reprod Biomed Online. 2015; 30(1): 101-110.
18. Sacchinelli A, Venturella R, Lico D, Di Cello A, Lucia A, Rania E, et al. The efficacy of inositol and N-Acetyl cysteine administration (Ovaric HP) in improving the ovarian function in infertile women with PCOS with or without insulin resistance. Obstet Gynecol Int J. 2014; 2014: 1-5.
19. Cheraghi E, Mehranjani MS, Shariatzadeh MA, Esfahani MH, Ebrahimi Z. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev. 2016; 28(6): 723-731.
20. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003. consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25.
21. Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002; 77(6): 1128-1135.
22. Elnashar A, Fahmy M, Mansour A, Ibrahim K. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate–resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertil Steril. 2007; 88(2): 406-409.
23. Oner G, Muderris II. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011; 159(1): 127-131.
24. Wei LN, Liang XY, Fang C, Zhang MF. Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome. Fertil Steril. 2011; 96(2): 464-468.
25. Dumesic DA, Abbott DH. Implications of Polycystic ovary syndrome (pcos) on oocyte development. Semin Reprod Med. 2008; 26(1): 53-61.
26. Surcel M, Stamatian F. Folliculogenesis disturbances within the polycystic ovarian syndrome and possible consequences on oocyte quality. Acta Endocrinologica (Buc). 2012; 8(2): 267-287.
27. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004; 25(1): 72-101.
28. Wu YT, Tang L, Cai J, Lu XE, Xu J, Zhu XM, et al. High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod. 2007; 22(6): 1526-1531.
29. Wei LN, Li LL, Fang C, Huang R, Liang XY. Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS. J Assist Reprod Genet. 2013; 30(10): 1313-1318.
30. Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev. 2011; 78(1): 9-21.
31. Brankin V, Hunter MG, Horan TL, Armstrong DG, Webb R. The expression patterns of Mrna-encoding stem cell factor, internal stem cell factor and c-kit in the prepubertal and adult porcine ovary. J Anat. 2004; 205(5): 393-403.
32. Hutt K, McLaughlin EA, Holland MK. Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Hum Reprod. 2006; 12(2): 61-69.
33. De Flora S, Izzotti A, D'Agostini F, Balansky RM. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis. 2001; 22(7): 999-1013.
34. Liu K. Stem cell factor (SCF)-kit mediated phosphatidylinositol 3 (PI3) kinase signaling during mammalian oocyte growth and early follicular development. Front Biosci. 2006; 11: 126-135.
35. Tanikawa M, Harada T, Mitsunari M, Onohara Y, Iwabe T, Terakawa N. Expression of c-kit messenger ribonucleic acid in human oocyte and presence of soluble c-kit in follicular fluid. J Clin Endocrinol Metab. 1998; 83(4): 1239-1242.
36. Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril. 2010; 94(1): 198-204.